In AD patients, cortical neuronal loss has been linked with elevated concentrations of T-tau in CSF [21,22,23], and high CSF T-tau concentrations have been clinically correlated with rapid cognitive decline in AD and show utility as a marker of disease stage [24]. Here, MAPT is linked to Alzheimer disease.